Novel mutations in response to vitamin B6 in primary hyperoxaluria type 1 after only kidney transplantation: a case report

Recently, the mainstream curative treatment for primary hyperoxaluria type 1 (PH1) is combined liver and kidney transplantation, and only kidney transplantation is considered ineffective for most PH1 patients. Furthermore, vitamin B6 (B6) is the only permitted drug available for treatment. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yuanyuan, Yang, Yang, Zhou, Ping, Jiang, Jipin, Chen, Zhishui, Du, Dunfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807321/
https://www.ncbi.nlm.nih.gov/pubmed/33457257
http://dx.doi.org/10.21037/tau-20-979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807321/
https://www.ncbi.nlm.nih.gov/pubmed/33457257
http://dx.doi.org/10.21037/tau-20-979

Ejemplares similares